Skip to main content
Type at least 3 characters

747 articles

Clinical Trial

Published on 16 Oct 2023

Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma—a phase II trial of the AIO study group (AIO STO 0321)

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

  • Joseph Tintelnot
  • Alexander Stein
  • Salah-Eddin Al-Batran
  • Thomas Ettrich
  • Thorsten Götze
  • Barbara GrĂĽn
  • Georg Martin Haag
  • Vera Heuer
  • Ralf-Dieter Hofheinz
  • Nils Homann
Frontiers in Oncology
doi 10.3389/fonc.2023.1272175
  • 4,545 views
  • 8 citations

Original Research

Published on 10 Oct 2023

Involved-field irradiation or elective-nodal irradiation in neoadjuvant chemo-radiotherapy for locally-advanced esophageal cancer: comprehensive analysis for dosimetry, treatment-related complications, impact on lymphocyte, patterns of failure and survival

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

  • Xianyan Chen
  • Yingjie Zhang
  • Xiaojuan Zhou
  • Min Wang
  • Feifei Na
  • Lin Zhou
  • Yong Xu
  • Bingwen Zou
  • Jianxin Xue
  • Yongmei Liu
Frontiers in Oncology
doi 10.3389/fonc.2023.1274924
  • 2,153 views
  • 3 citations

Clinical Trial

Published on 29 Sep 2023

Study protocol of a phase II clinical trial evaluating the efficacy of neoadjuvant intraperitoneal and systemic albumin-bound paclitaxel combined with camrelizumab and S-1 in the treatment of patients with exfoliative cell-positive gastric cancer

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

  • Jingxia Lv
  • Jiaxiang Wu
  • Haotian Wu
  • Ping’an Ding
  • Honghai Guo
  • Peigang Yang
  • Yuan Tian
  • Yang Liu
  • Qun Zhao
Frontiers in Oncology
doi 10.3389/fonc.2023.1201928
  • 2,715 views